Skip to main content Accessibility help
×
Home

Schizophrenia, antipsychotics and diabetes: Genetic aspects

  • F. Bellivier (a1) (a2)

Abstract

The relatively high comorbidity of type 2 diabetes and schizophrenia may suggest a shared biological susceptibility to these twoconditions. Family studies have demonstrated an increased risk of diabetes in unaffected relatives of patients with schizophrenia, consistent with a heritable susceptibility trait. Linkage analyses have identified several loci that are associated with schizophrenia and some of these, notably those on chromosomes 2p22.1-p13.2 and 6g21-824.1 have also been observed in linkage studies in type 2 diabetes. In addition, the dopamine D5 receptor on chromosome 5 and the tyrosine hydroxylase gene on chromosome 11 have both been suggested as candidate genes in schizophrenia and may also be implicated in susceptibility to poor glycaemic control. In addition, an increased rate of type II diabetes has been observed in some patients treated with antipsychotics. Potential neurochemical substrates of this effect include the histamine H1 receptor, the 5-HT2C serotonin receptor or the β3 adrenoreceptor. However, the search for a genetic basis to the association between diabetes and schizophrenia is still in its infancy, and much further work needs to be performed, including the systematic screening of all confirmed susceptibility loci and quantitative trait locus mapping of glycaemic control.

Copyright

Corresponding author

E-mail address: bellivier@im3.inserm.fr (F. Bellivier).

References

Hide All
[1]Allison, D.B.Casey, D.E.Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry. 2001; 62Suppl 7: 2231
[2]Aschauer, H.N.Fischer, G.Isenberg, K.E.Meszaros, K.Willinger, U., et al.No proof of linkage between schizophrenia-related disorders including schizophrenia and chromosome 2g21 region. Eur Arch Psychiatry Clin Neurosci. 1993; 243: 193–8
[3]Asherson, P.Mant, R.Williams, N.Cardno, A.Jones, L., et al.A study of chromosome 4p markers and dopamine D5 receptor gene in schizophrenia and bipolar disorder. Mot Psychiatry. 1998; 3: 310–20
[4]Blackwood, D.H.He, L.Morris, S.W.McLean, A.Whitton, C., et al.A locus for bipolar affective disorder on chromosome 4p. Nat Genet. 1996; 12: 427–30
[5]Blasi, C.Pierelli, F.Rispoli, E.Saponara, M.Vingolo, E.Andreani, D.Wolfram's syndrome: a clinical, diagnostic, and interpretative contribution. Diabetes Care. 1986; 9: 521–8
[6]Cheta, D.Dumitrescu, C.Georgescu, M.Cocioaba, G.Lichiardopol, R., et al.A study on the types of diabetes mellitus in first degree relatives of diabetic patients. Diabete Metab. 1990; 16: 11–5
[7]Chiba, M.Suzuki, S.Hinokio, Y.Hirai, M.Satoh, Y., et al.Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism. 2000; 49: 1145–9
[8]Collier, D.A.Barrett, T.G.Curtis, D.Macleod, A.Arranz, M.J., et al.Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity. Am J Hum Genet. 1996; 59: 855–63
[9]Collin, G.B.Marshall, J.D.Cardon, L.R.Nishina, P.M.Homozygosity mapping at Alstrom syndrome to chromosome 2p. Hum Mot Genet. 1997; 6: 213–9
[10]Crow, T.J.DeLisi, L.E.Johnstone, E.C.Concordance by sex in sibling pairs with schizophrenia is paternally inherited. Evidence for a pseudoautosomal locus. Br J Psychiatry. 1989; 155: 92–7
[11]DeLisi, L.E.Shaw, S.H.Crow, T.J.Shields, G.Smith, A.B., et al.A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry. 2002; 159: 803–12
[12]Demenais, F.Kanninen, T.Lindgren, C.M.Wiltshire, S.Gaget, S., et al.A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Hum Mot Genet. 2003; 12: 1865–73
[13]Dynes, J.B.Diabetes in schizophrenia and diabetes in nonpsychotic medical patients. Dis New Syst. 1969; 30: 341–4
[14]Ekelund, J.Lichtermann, D.Hovatta, I.Ellonen, P.Suvisaari, J., et al.Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mot Genet. 2000; 129: 1049-57
[15]Eubanks, J.H.Altherr, M.Wagner-McPherson, C.McPherson, J.D.Wasmuth, J.J.Evans, G.A.Localization of the D5 dopamine receptor gene to human chromosome 4p15.1-p15.3, centromeric to the Huntington's disease locus. Genomics. 1992; 12: 510–6
[16]Evans, K.L.Lawson, D.Meitinger, T.Blackwood, D.H.Porteous, D.J.Mutational analysis of the Wolfram syndrome gene in two families with chromosome 4p-linked bipolar affective disorder. Am J Med Genet. 2000; 96: 158–60
[17]Faraone, S.V.Matise, T.Svrakic, D.Pepple, J.Malaspina, D., et al.Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet. 1998; 81: 290–5
[18]Freedman, R.Coon, H.Myles-Worsley, M.Orr-Urtreger, A.Olincy, A., et al.Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 1997; 94: 587-92
[19]Fujisawa, T.Ikegami, H.Yamato, E.Takekawa, K.Nakagawa, Y., et al.Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia. 1996; 39: 349–52
[20]Goudie, A.J.Halford, J.C.Dovey, T.M.Cooper, G.D.Neill, J.C.H(1)histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003; 28: 2209
[21]Hager, J.Dina, C.Francke, S.Dubois, S.Houari, M., et al.A genomewide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet. 1998; 20: 304–8
[22]Hovatta, I.Varilo, T.Suvisaari, J.Terwilliger, J.D.Ollikainen, V., et al.A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet. 1999; 65: 1114–24
[23]Inoue, H.Tanizawa, Y.Wasson, J.Behn, P.Kalidas, K., et al.A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet. 1998; 20: 143–8
[24]Kaneda, Y.Fujii, A.Ohmori, T.The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics. Prog Neuropsychopharmacol Biol Psychiatry. 2002; 26(5): 935-8
[25]Kaufmann, C.A.Suarez, B.Malaspina, D.Pepple, J.Svrakic, D., et al.NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet. 1998; 81: 282–9
[26]Kendler, K.S.Gruenberg, A.M.Kinney, D.K.Independent diagnoses of adoptees and relatives as defined by DSM-III in the provincial and national samples of the Danish Adoption Study of Schizophrenia. Arch Gen Psychiatry. 1994; 51: 456–68
[27]Kikuchi, M.Yamada, K.Toyota, T.Itokawa, M.Hattori, E., et al.Two-step association analyses of the chromosome 18p11.2 region in schizophrenia detect a locus encompassing C18orf1. Mol Psychiatry. 2003; 8: 467–9
[28]Kopecky, J.Flachs, P.Bardova, K.Branner, P.Prazak, T.Sponarova, J.Modulation of lipid metabolism by energy status of adipocytes:implications for insulin sensitivity. Ann N Y Acad Sci. 2002; 967: 88101
[29]Kroeze, W.K.Hufeisen, S.J.Popadak, B.A.Renock, S.M.Steinberg, S.Ernsberger, P.Jayathilake, K.Meltzer, H.Y.Roth, B.L.H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology. 2003; 28: 519–26
[30]Lin, M.W.Curtis, D.Williams, N.Arranz, M.Nanko, S., et al.Suggestive evidence for linkage of schizophrenia to markers on chromosome 13814.1-q32. Psychiatr Genet. 1995; 5: 117–26
[31]Lorenz, W.F.Sugar tolerance in dementia praecox and other mental disorders. Arch Neurol Psychiatry. 1922; 8: 184–96
[32]McGuffin, P.Tandon, K.Corsico, A.Linkage and association studies of schizophrenia. Curr Psychiatry Rep. 2003; 5: 121–7
[33]McIntyre, E.A.Walker, M.Genetics of type 2 diabetes and insulin resistance: knowledge from human studies. Clin Endocrinol. 2002; 57: 303–11
[34]Mitchell, B.D.Cole, S.A.Hsueh, W.C.Comuzzie, A.G.Blangero, J., et al.Linkage of serum insulin concentrations to chromosome 3p in Mexican Americans. Diabetes. 2000; 49: 513–6
[35]Mukherjee, S.Schur, D.B.Reddy, R.Family history of type 2 diabetes in schizophrenic patients. Lancet. 1989; 333: 495
[36]Pulver, A.E.Karayiorgou, M.Wolyniec, P.S.Lasseter, V.K.Kasch, L., et al.Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. Am J Med Genet. 1994; 54: 3643
[37]Pulver, A.E.Lasseter, V.K.Kasch, L.Wolyniec, P.Nestadt, G., et al.Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet. 1995; 60: 252–60
[38]Regenold, W.T.Thapar, R.K.Marano, C.Gavirneni, S.Kondapavuluru, P.V.Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord. 2002; 70: 1926
[39]Riley, B.P.Williamson, R.Non-parametric analysis of chromosome 6p24-22 marker data and schizophrenia in southern African Bantuspeaking families. Psychiatr Genet. 1997; 7: 131–2
[40]Ryan, M.C.M.Collins, P.Thakore, J.H.Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003; 160: 284–9
[41]Sernyak, M.J.Leslie, D.L.Alarcon, R.D.Losonczy, M.F.Rosenheck, R.Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry. 2002; 159: 561–6
[42]Shayegan, D.K.Stahl, S.M.Atypical antipsychotics: matching receptor profile to individual patient's clinical profile. CNS Spear. 2004; 910(Suppl 11): 614
[43]Sten-Linder, M.Wedell, A.Iselius, L.Efendic, S.Luft, R.Luthman, H.DNA polymorphisms in the human tyrosine hydroxylase/insulin/ insulin-like growth factor II chromosomal region in relation to glucose and insulin responses. Diabetologia. 1993; 36: 2532
[44]Tabata, H.Kikuoka, M.Kikuoka, H.Bessho, H.Hirayama, J., et al.Characteristics of diabetes mellitus in schizophrenic patients. J Med Assoc Thai. 1987; 70(Suppl 2): 90-3
[45]Tecott, L.H.Sun, L.M.Akana, S.F.Strack, A.M.Lowenstein, D.H., et al.Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 1995; 374: 542–6
[46]Tejedor-Real, P.Faucon Biguet, N.Dumas, S.Mallet, J.Tyrosine hydroxylase mRNA and protein are down-regulated by chronic clozapine in both the mesocorticolimbic and the nigrostriatal systems. J Neurosci Res 7212003 105-15
[47]Torres, R.Leroy, E.Hu, X.Katrivanou, A.Gourzis, P., et al.Mutation screening of the Wolfram syndrome gene in psychiatric patients. Mol Psychiatry. 2001; 6: 3943
[48]Wang, S.Sun, C.E.Walczak, C.A.Ziegle, J.S.Kipps, B.R., et al.Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet. 1995; 10: 41–6
[49]Williams, N.M.Rees, M.I.Holmans, P.Norton, N.Cardno, A.G., et al.A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet. 1999; 8: 1729–39
[50]Wolford, J.K.Gruber, J.D.Ossowski, V.M.Vozarova, B.Antonio Tataranni, P., et al.A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians. Mol Genet Metab. 2003; 78: 136–44
[51]Wolford, J.K.Konheim, Y.L.Colligan, P.B.Bogardus, C.Association of a F479L variant in the cytosolic phospholipase A2 gene (PLA2G4A) with decreased glucose turnover and oxidation rates in Pima Indians. Mol Genet Metab. 2003; 79: 61–6

Keywords

Schizophrenia, antipsychotics and diabetes: Genetic aspects

  • F. Bellivier (a1) (a2)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Schizophrenia, antipsychotics and diabetes: Genetic aspects

  • F. Bellivier (a1) (a2)
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *